Soliris (eculizumab) and Ultomiris (ravulizumab-cwvz) are medications developed by Alexion to treat atypical hemolytic uremic syndrome…
Articles by Emily Malcolm, PhD
Soliris (eculizumab) is a medication developed by Alexion to treat atypical hemolytic uremic syndrome (aHUS).
Ultomiris (ravulizumab-cwvz) is a treatment for atypical hemolytic uremic syndrome (aHUS) that was developed by Alexion.
Being diagnosed with a rare disease like atypical hemolytic uremic syndrome (aHUS) can be frightening, especially as this…
A skin biopsy is one of the tests that doctors can use to confirm a diagnosis of…
Only a few treatment options exist for atypical hemolytic uremic syndrome (aHUS) and there’s currently no cure for…
Living with a rare disease like atypical hemolytic uremic syndrome (aHUS) can be challenging. Given how rare aHUS…
Finding out that you have a rare disease like atypical hemolytic uremic syndrome (aHUS) can be confusing and…
Atypical hemolytic uremic syndrome (aHUS) is a rare disease characterized by the formation of small blood clots in…
Atypical hemolytic uremic syndrome (aHUS) is a rare disease characterized by the formation of blood clots in the…